RMTI Similar Chart Price Prediction
The price of RMTI is predicted to go up 5.05%, based on the high correlation periods with KELYA. The similarity of these two price pattern on the periods is 98.41%.
RMTI
KELYA
Up: 5.05%Similarity: 98.41%
RMTI Revenue Forecast
RMTI EPS Forecast
RMTI FAQs
What is RMTI revenue forecast for next quarter？
RMTI Analyst's Forecast
Brandon Folkes
Rodman & Renshaw
Strong Buy
2024-11-14
Price Target
$5
Upside
+100.8%
Rodman & Renshaw initiated coverage of Rockwell Medical with a Buy rating and $5 price target. Rockwell has been a leading provider of dialysis concentrates in the U.S. for over 20 years, supplying essential concentrates used in dialysis machines to help patients with kidney issues, the analyst tells investors in a research note. The firm says that with expected revenue of over $65M in 2025 and potential for further gross margin improvement, the company remains undervalued despite the challenges of heavy customer concentration risk.
